Novel Sox10 enhancer and validated Sox9 as direct target for AKT. »
05/13/21

Close collaboration with patients throughout process intrinsic for developing PEX-LC. »
05/13/21

Potential use of topical TAPP for treatment of actinic keratosis and skin adnexal neoplasms. »
05/13/21

Commonly used hypofractionated radiotherapy regimen associated with lower biochemical control. »
05/12/21

Lasofoxifene more effective than fulvestrant at inhibiting primary tumor growth. »
05/12/21

Apoptosis induced by bifidobacteria secretion metabolites. »
05/12/21

WT EpCAM, but not C66Y EpCAM, inhibits CTSL activity in vitro. »
05/12/21

Median dose of stereotactic radiosurgery 21 Gy. »
05/15/21

late ALs had significant negative impact on risk of DFS. »
05/21/21

Fulvestrant alone impacted tumor growth. »
05/21/21